Table 7.
Distance traveled (activity [arbitrary units]; mean ± 1 SD) until ataxia and nose down
| 15% CO2 | 30% CO2 | 50% CO2 | 100% CO2 | Isoflurane | Pentobarbital– phenytoin | P | |
| Ataxia activity | 458 ± 606 | 334 ± 96.7b | 168.5 ± 157.4a,b | 148.4 ± 81.3a,b | 723 ± 734 | 766 ± 411 | <0.0001 |
| Ataxia activity/s | 6.5 ± 9.8b | 7.0 ± 5.7ab | 5.3 ± 4.4a,b | 6.2 ± 3.5a,b | 24.3 ± 27.8 | 22.7 ± 10.8 | <0.0001 |
| Nose down activity | 627 ± 673b | 574 ± 382b | 273 ± 185.2a,b | 181.4 ± 109.8a,b | 835 ± 267 | 2043 ± 674 | <0.0001 |
| Nose down activity/s | 6.1 ± 6.6b | 8.4 ± 5.9b | 5.7 ± 3.4a,b | 5.7 ± 3.4a,b | 14.0 ± 4.8 | 22.0 ± 9.9 | <0.0001 |
CO2 data have been published previously.2
Significantly different from isoflurane.
Significantly different from pentobarbital–phenytoin.